Cargando…
Clinical and pathologic factors predicting reclassification in active surveillance cohorts
The incidence of small, lower risk well-differentiated prostate cancer is increasing and almost half of the patients with this diagnosis are candidates for initial conservative management in an attempt to avoid overtreatment and morbidity associated with surgery or radiation. A proportion of patient...
Autores principales: | Sierra, Pablo S., Damodaran, Shivashankar, Jarrard, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Urologia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996796/ https://www.ncbi.nlm.nih.gov/pubmed/29368876 http://dx.doi.org/10.1590/S1677-5538.IBJU.2017.0320 |
Ejemplares similares
-
Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection
por: Jarrard, William E., et al.
Publicado: (2019) -
Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?
por: Roscigno, Marco, et al.
Publicado: (2020) -
Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier
por: Etheridge, Tyler, et al.
Publicado: (2019) -
PB2116: CASTLEMAN’S DISEASE: DIFFERENT CLINICAL BEHAVIOR AND PATHOLOGIC RECLASSIFICATION OF A COHORT OF MEXICAN PATIENTS
por: Collazo, Alfonso Orozco, et al.
Publicado: (2023) -
The impact of baseline [−2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort
por: Hirama, Hiromi, et al.
Publicado: (2013)